Vericel Corp (VCEL)

• Market cap: $2.04B
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

187% more call options, than puts

Call options by funds: $5.55M | Put options by funds: $1.93M

13% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 31

2% more funds holding

Funds holding: 252 [Q1] → 256 (+4) [Q2]

3% more repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 91

3.06% less ownership

Funds ownership: 107.18% [Q1] → 104.12% (-3.06%) [Q2]

14% less capital invested

Capital invested by funds: $2.7B [Q1] → $2.32B (-$375M) [Q2]

60% less funds holding in top 10

Funds holding in top 10: 5 [Q1] → 2 (-3) [Q2]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $57 36% upside
• Avg. target: $58 39% upside
• High target: $60 43% upside

5 analyst ratings

• positive: 5 100%
• neutral: 0 0%
• negative: 0 0%

TD Cowen Joshua Jennings 60% 1-year accuracy 9 / 15 met price target	43% upside $60	Buy Maintained	27 Aug 2024
Canaccord Genuity Caitlin Cronin 27% 1-year accuracy 3 / 11 met price target	36% upside $57	Buy Initiated	9 Aug 2024
Stephens & Co. George Sellers 27% 1-year accuracy 4 / 15 met price target	38% upside $58	Overweight Maintained	2 Aug 2024
HC Wainwright & Co. Swayampakula Ramakanth 24% 1-year accuracy 28 / 116 met price target	43% upside $60	Buy Maintained	2 Aug 2024
Truist Securities Samuel Brodovsky 78% 1-year accuracy 7 / 9 met price target	36% upside $57	Buy Maintained	16 Jul 2024